Cerenome, Inc. (CNSY)

Cerenome, Inc. (CNSY) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $12.9M; returns 1 day -6.3%, 1 week -3.5%.

Cerenome, Inc. (CNSY), formerly known as Plus Therapeutics, Inc., is a clinical-stage biotechnology company that transitioned in July 2026 into an integrated Central Nervous System (CNS) oncology specialist. The company focuses on a multimodal approach to treating rare and high-unmet-need CNS cancers, specifically glioblastoma and leptomeningeal metastases.

Groups CNSY belongs to

• Biotechnology
• Recent Reverse Splits
• Oncology
• CNS Disorders
• Healthcare
• Clinical Stage Biopharma
• Precision Medicine
• Clinical Stage
• Unmet Medical Needs
• Biopharmaceutical
• Rare Diseases
• Health Diagnostics and Imaging
• Life Sciences

CNSY financial model: income statement, cash flow and balance sheet